- Home
- KOD vs BRSP Comparison
KOD vs BRSP Comparison
Compare KOD & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | BRSP |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 683.8M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KOD | BRSP |
|---|---|---|
| Price | $22.87 | $5.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $22.29 | $6.00 |
| AVG Volume (30 Days) | ★ 774.9K | 757.5K |
| Earning Date | 11-13-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 11.45% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $330,894,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $4.16 |
| 52 Week High | $23.63 | $6.45 |
Technical Indicators
Market Signals| Indicator | KOD | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 60.69 |
| Support Level | $19.25 | $5.32 |
| Resistance Level | $23.63 | $5.70 |
| Average True Range (ATR) | 1.92 | 0.11 |
| MACD | 0.24 | 0.03 |
| Stochastic Oscillator | 89.70 | 68.42 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.